Developmental and Neurobehavioral Toxicity of Hexaphenoxycyclotriphosphazene: Implications for Its Safety as a Flame-Retardant Alternative to Triphenyl Phosphate by Ruobing Bai (4860043)

“…HPCTP caused dose-dependent depression-like behaviors (hypoactivity, light-zone avoidance) through suppression of serotonin 1A (5-HT₁A) signaling, supported by decreased <i>htr1aa</i> expression and serotonin levels and partially rescued by the 5-HT₁A receptor agonist 8-OH-DPAT. …”

Average methylation and coverage across technologies. by Amy Longtin (21409957)

S1 File - by Natalia V. Leiva (20114264)

“…However, at the higher copper concentration (6 mg/L), survival was negatively impacted (50%) at 54 hours. …”

Thiolutin, a selective NLRP3 inflammasome inhibitor, attenuates cyclophosphamide–induced impairment of sperm and fertility in mice by Pengfei Zhu (673309)

“…</p> <p>OA patients exhibited a decrease in sperm density and motility compared to healthy individuals, along with elevated levels of IL-1β, IL-18 and NLRP3 inflammasome. …”

DataSheet1_v1_Insights Into Nickel Slag Carbonation in a Stirred Bead Mill.docx by Carine Julcour (5773055)

“…The results obtained indicate that the observed slowing down of the carbonation process can be explained either by the formation of Mg- and/or Fe-rich silicates that precipitate at the expense of carbonates, or by a decrease in the efficiency of the attrition process over time. …”

A reduction in brain mass and cortical volume seen in the adult <i>Cln6^nclf</i> mouse. by Jeremy P. Morgan (479017)

“…<p>Brain mass was assessed in the <i>Cln6^nclf</i>, as a decrease in brain mass is often seen in vLINCL patients. …”

New advances in <i>DPYD</i> genotype and risk of severe toxicity under capecitabine - Fig 3 by Marie-Christine Etienne-Grimaldi (413881)

“…<p>Distribution of pre-treatment plasma UH2/U ratio (A) and Uracil concentrations (B) for the 205 patients with validated phenotypic data, according to <i>DPYD</i> variants of interest: variant *2A (3 heterozygous patients), D949V (3 heterozygous patients), R592W (1 heterozygous patient), D342G (1 heterozygous patient), HapB3 (4 heterozygous patients), 166VV (3 homozygous patients) <i>vs</i> any other variations (185 patients) <i>vs</i> no variation (5 patients). …”

Postprandial changes in (A) serum free fatty acid and (B) cortisol after mood inductions. by Ilse C. Schrieks (512142)

Average behaviour of Tajima’s <i>D</i> during a crash and recovery in parasite prevalence. by Jason A. Hendry (11302608)

Frequency trajectories of iSNVs that fluctuated (Top) and their positions on the genome (Bottom) (patients A-I). by Lele Zhao (532080)

“…<p>The inclusion criterion was iSNVs that changed from below 50% at Baseline (i.e., 0 days post baseline), to above 50% at PT12 (12 weeks post treatment), and decreased to below 50% at PT24 (24 weeks post treatment). …”

NF-κB and apoptotic signals <i>in vivo</i>. by Naoki Takada (2728912)

“…<p>(A) p65 concentration in the excised tumors significantly increased in the radiation group compared with that in the control group (893.6 ± 91.0 ng/mg protein vs. 628.5 ± 146.1 ng/mg protein, p < 0.05). p65 expression in the combination group was lower than that in the radiation group (375.93 ± 201.3 ng/mg protein vs. 893.6 ± 91.0 ng/mg protein, p < 0.01). …”

Adverse event list. by Stefan Halbherr (21353882)

“…</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”

Patient characteristics. by Stefan Halbherr (21353882)

“…</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”

The impact of fishing on a highly vulnerable ecosystem, the case of Juan Fernández Ridge ecosystem - Fig 5 by Javier Porobic (6392612)

“…Note that the y-axes is the ratio of change against the starting conditions—so a -0.5 result indicates a 50% decrease and a 0.5 result indicates a 50% increase -.…”

Rate of hydrolysis of MTX-CONH-(CH₂)₆-NH₂ from PEG₄₀-CONH-(CH₂)₅-CONH-(CH₂)₆-NHCO-MTX at aci... by Itzik Cooper (2873291)

“…<p>Rate of hydrolysis was determined by the decrease in the absorbance of the PEG₄₀-MTX conjugate at 305nm as a function of time during dialysis against 1mM HCl (pH 3.0) or 50 mM Hepes buffer (pH 7.4). …”

A Low-Cost Beam-Scanning Second Harmonic Generation Microscope with Application for Agrochemical Development and Testing by Benjamin A. Grubbs (7326698)

Comparative Hazard Identification by a Single Dose Lung Exposure of Zinc Oxide and Silver Nanomaterials in Mice by Ilse Gosens (388749)

Comparative Proteomic Profiling of 3T3-L1 Adipocyte Differentiation Using SILAC Quantification by Sunkyu Choi (2141545)

ProBDNF treatment increases RhoA activity and filopodial length on DRG growth cones. by Ying Sun (23237)

Effect of a physiotherapy program in patient with persistent polyarthralgia after chikungunya fever. Case report by Alexsandro da Silva Oliveira (4718397)